UBS: Downgrades Shangri-La Asia (00069) target price to HKD 4.29, maintains "Neutral" rating.

11:26 03/09/2026

The bank has lowered its diluted earnings per share forecast for the company for 2027-2028 by 7% and 12%, to $0.05 and $0.06, respectively, to reflect ongoing macroeconomic uncertainty and consumer downgrading, while the 2026 forecast remains largely unchanged at $0.05.

UBS released a research report indicating that it has lowered the target price for Shangri-La Asia (00069) from HKD 4.55 to HKD 4.29 and maintains a "Neutral" rating. Shangri-La's revenue for the first half of the year met expectations, and the company remains cautiously optimistic about the industry outlook for the second half, but anticipates that geopolitical conflicts and extreme weather will bring short-term volatility. The bank has reduced its earnings per share forecasts for the company for 2027-2028 by 7% and 12% to USD 0.05 and USD 0.06, respectively, to reflect ongoing macro uncertainties and consumer downgrading, while the forecast for 2026 is roughly unchanged at USD 0.05.

Hong Kong Stock Concept Tracker | AICC2026 Artificial Intelligence Computing Conference to Be Held; Institutions Suggest Continued Focus on Computing Power Services, Domestic Chips, and More (with Concept Stocks)

CUTIA-B(02487): CU-40102 (topical finasteride spray) receives marketing approval from the Pharmaceutical Administration Bureau of Macau

A-Share Subscription | Yute Optoelectronics (920157.BJ) Opens Subscription, Focused on R&D, Design, Precision Manufacturing, and Sales of Optical Connectivity Products

CUTIA-B(02487): CU-40102 (topical finasteride spray) receives marketing approval from the Pharmaceutical Administration Bureau of Macau

A-Share Subscription | Yute Optoelectronics (920157.BJ) Opens Subscription, Focused on R&D, Design, Precision Manufacturing, and Sales of Optical Connectivity Products